EZYPOR® is FCI ultimate high density polyethylene orbital implant indicated for enucleation, evisceration and secondary implantation. EZYPOR® comes with a unique and patented smooth anterior suturing platform with 8 suture tunnels, allowing for multiple suturing options.

Last update : June 2023

Last update : November 2023

FCI S.A.S. is a world leader in the development of a wide range of ophthalmic surgical devices. Since the company’s inception in 1984, the innovative developments of FCI have helped physicians to solve problems related to epiphora, dry eye, eyelids, and orbital surgery as well as retinal detachment : highly purified silicone oil and perfluorocarbons, scleral buckling implants, and a wide range of other ophthalmic surgical devices such as disposable vitrectomy lenses, single use instruments and directional laser probes.

FCI S.A.S. is a world leader in the development of a wide range of ophthalmic surgical devices. Since the company’s inception in 1984, the innovative developments of FCI have helped physicians to solve problems related to epiphora, dry eye, eyelids, and orbital surgery, thanks to a wide range of innovative ophthalmic devices such as self-retaining intubation sets, lacrimal balloon catheter, injectable monocanalicular intubation, permanent punctal plugs, eyelids and orbital implants.

FCI S.A.S. is a world leader in the development of a wide range of ophthalmic surgical devices. Since the company’s inception in 1984, the innovative developments of FCI have helped physicians to solve problems related to epiphora, dry eye, eyelids, and orbital surgery, thanks to a wide range of innovative ophthalmic devices and reusable instruments.

FCI Nunchaku® is a pushed silicone self-retaining bicanalicular nasolacrimal intubation stent that acts like a conformer, allowing tears to be drained by capillarity. The metallic guides are located inside the lumen, not as an extension of the stent as in conventional intubation sets. Therefore, no nasal retrieval is needed.

We would like to thank Kenneth V. Cahill , M.D. for his contribution to this video.

RetiLock®offers an exclusive and patented design for both routine and complex vitrectomy procedures. Its cannula presents an autostable ring of increased diameter, designed to sit on the inner aspect of the pars plana. The beauty of this design is to increase the stability and decrease the risk of cannula dislocation during complex cases with multiple instrument exchanges.

The StopLoss™ Jones tube introducer set enables the surgeon to choose the most appropriate diameter and length of the StopLoss™ Jones tube prior to tube insertion.

The new StopLoss™ Jones tube system puts an end to the high loss rate of ordinary Jones tubes yet is safe, effective and easy to use.